Koszty Operacyjne Zmiana Data
AstraZeneca USD 12.53B 4.16B 2025-12
Autolus Therapeutics Ltd USD 82.61M 8.39M 2025-06
Hikma Pharmaceutical USD 1.34B 702M 2025-12
Novartis USD 9.86B 115M 2025-09
Roche Holding CHF 21.01B 10.84B 2025-12
Silence Therapeutics USD 23.68M 4.76M 2024-09